申请人:Sorrento Therapeutics, Inc.
公开号:US20170107289A1
公开(公告)日:2017-04-20
Provided are compounds having the Formula I:
pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and their use in the intracellular delivery of antibodies.